ArticleJournal of hepatology2022

ADAMTSL2 protein and a soluble biomarker signature identify at-risk non-alcoholic steatohepatitis and fibrosis in adults with NAFLD.

Kathleen E Corey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.